{"schema_version":"secwatch.filing_event.v1","accession":"0000730464-25-000007","form_type":"8-K","ticker":"CVSA","cik":"0000730464","company_name":"Covista Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.124464+00:00","generated_at":"2026-05-22T06:02:00.224725+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Adtalem Q3 FY2025 EPS $1.59 ($1.92 adj.), revenue $466.1M +12.9%; raises FY guidance","bullets":["Revenue $466.1M (+12.9% YoY); diluted EPS $1.59 (adj. $1.92, +28% YoY); net income $60.8M.","Total enrollment up 9.8% to 94,223; Chamberlain +6.8%, Walden +13.5%, Med/Vet +1.2%.","Completed $300M share repurchase program; new $150M authorization through May 2028.","FY2025 guidance raised: revenue $1,760-1,775M, adj. EPS $6.40-$6.60 (28-32% YoY growth).","Adjusted EBITDA $127.8M (+19.3% YoY); margin 27.4% vs 25.9% prior year."],"urls":{"canonical":"https://secwatch.observer/filing/0000730464-25-000007","json":"https://secwatch.observer/filing/0000730464-25-000007.json","markdown":"https://secwatch.observer/filing/0000730464-25-000007.md","text":"https://secwatch.observer/filing/0000730464-25-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/730464/000073046425000007/0000730464-25-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/730464/000073046425000007/atge-20250508x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T06:02:00.224725+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}